A corporate in your sector offers to lead the round. The valuation is better than the funds you have been talking to, the diligence is lighter, and they want a board observer seat and a right of first refusal on any sale.
Nothing here is a trick. Ask what those terms are buying, because a price better than the market’s is a statement about what else is being purchased.
Why these three models
The decision is whether to take strategic or corporate money, and which terms to refuse if you do. The features that fire are an offer whose availability is itself information, a relationship that reaches the rest of your commercial network, and a set of future buyers who will read your register before they read your numbers.
Three lenses. Selection produces an equilibrium answer about why this offer exists at this price. Spread produces a cycle answer about where the relationship travels once it exists. Observational learning produces a complex answer about how other acquirers read it. The third is the one that operates years later, which is why it is almost never in the room.
1. Why is this available to you
The first question is not whether the terms are good. It is why they are these terms.
A financial investor is buying a return, so their price reflects their view of your returns. A strategic investor is buying a return plus something else: a view of your market, an option on acquiring you, a way to slow a competitor, or a relationship with your customers. When someone is buying more than one thing and paying one price, the price stops being a clean statement about the first thing.1
So a valuation above what the funds offered is not evidence that the funds were wrong. It is evidence that this buyer is getting something the funds were not asking for, and your job is to name it.
Name it by looking at the terms rather than the number, because the terms are where the second purchase is written. A right of first refusal on a sale is an option on acquiring you, granted for free, that also depresses what any other buyer will bid. An information right that includes customer-level data is a market study. An observer seat with no obligations is a low-cost watching brief on a competitor they are considering building against.
None of that is bad faith and all of it is worth pricing. The productive move is to accept the money and refuse the free options: no right of first refusal, information rights limited to what other investors receive, and any commercial arrangement written as a separate agreement on arm’s-length terms with its own term and its own exit. If the offer only works with the options attached, you have learned what was actually being bought.
Expect a softened counter rather than a refusal. They will offer a right of first offer in place of a right of first refusal, which sounds like a concession and is not one until you read the mechanics. A first-offer right that makes you name your price first, then lets them match any later bid, is a first-refusal right with a longer sentence. The test is mechanical. Read the clause and ask whether they can see another buyer’s number before they have to decide. If they can, it is the same option, and it discounts every bid you receive for as long as it lives.
There is a cheaper version of this work for a founder who cannot pay a corporate lawyer to redraft a term sheet. Take the draft, list every clause that gives them a right your other investors do not get, and put a date on each one. Information rights that expire in twenty-four months. An observer seat that ends when their holding falls below a stated percentage. A first-look right that lapses if they do not exercise inside thirty days. Dates cost nothing to insert, they rarely trigger a fight, and they convert a permanent option into a temporary one, which is most of what you were giving away for free.
2. Where the relationship travels
The second lens tracks what happens after signature, in the parts of your business that were not represented in the negotiation.
A commercial relationship with a large company does not stay inside its contract. It reaches your customers, who may be their competitors. It reaches your suppliers, who may already be their suppliers. It reaches your hiring, because their people know your people now. Relationships spread along the connections that already exist, and the network you sit in is the one that determines where it goes.2
The consequence founders miss is that the spread is not symmetric. Their investment in you is one line in a portfolio, and your relationship with them is a defining fact about your company for everyone who deals with you.
To them you are a position, and to your market you are now their company.
That gives a concrete pre-signature exercise. List your ten largest customers and your five most important suppliers, and mark which of them compete with this investor or depend on them. If more than one or two are marked, the investment has a commercial cost you have not counted, and it will arrive as a slow reluctance rather than as a cancelled contract, which makes it hard to attribute later.
The mitigation is not secrecy, which fails and looks worse when it fails. It is sequencing: tell the affected customers yourself, before the announcement, with a specific statement of what does and does not change about their data and their terms.
The mark-up exercise fails in one predictable way in East African markets, where the competing party is often not visible on any register. Your largest distributor may be held by the same family that owns the investor’s local agent, and no filing will tell you that. So ask people rather than documents. Ask two of your distributors which other brands they carry and for whom. Ask your operations lead which of your suppliers takes instructions from the same warehouse. Twenty minutes of that finds relationships a corporate database in another country will never show you, and it is the same twenty minutes either way.
A second-order effect lands on your own team before any customer notices. Once a large corporate holds an observer seat, your managers start writing the board pack for that reader, and the honest number gets softened one step earlier in the chain than it used to be. The tell is the first month a target is missed and the pack explains the miss before it states it. Keep an internal operating review the observer does not attend, running the same numbers with no framing, so the softened version never becomes the only version anybody sees.
3. What every other buyer will infer
The third lens operates on a horizon the negotiation never reaches, and it is the one that decides what this costs.
When buyers cannot easily evaluate something directly, they use what other buyers have visibly done. Past a small number of visible choices in one direction, the rational move is to follow rather than to run your own assessment.3 A strategic investor sitting on your register is exactly that kind of visible choice, and it will be read by every acquirer who looks at you afterwards.
The reading is usually one of two things and you do not control which. Either this company is close to that group, which is why nobody else has bought them, or this company has already been looked at by the most informed buyer in the sector and not acquired. Both readings reduce competition for you later, and both operate without anyone examining your business.
The same asymmetry runs through everything they promise you commercially. In a relationship where their horizon is measured in decades and yours in quarters, an intention that is not specific and dated carries no weight, because nothing binds them to it and the person who offered it may not be there.4 A commercial promise without a date and a number is a description of a mood, and you are pricing it as an asset.
This is the argument that most changes the decision, and it is the one that never appears in the term sheet discussion, because its cost lands three to five years out and the benefit lands this quarter.
There is a timing point buried in this that founders get backwards. The cascade forms from a short opening sequence, which means the register you assemble in your first priced round does more work than any later one, and it does that work silently for years. Nobody tells you at the time, because the people who would read it are not looking at you yet.
It also suggests the specific defence. What breaks a cascade is a credible public fact that contradicts it, so the counterweight is a second strategic from a different group, or a financial lead that clearly priced the company on its own merits. A single strategic on a register with no financial anchor is the configuration that reads worst.
That defence has a failure mode worth naming before you reach for it. Two strategics from competing groups can freeze you rather than free you. Each one now watches the other, neither wants to fund a round the other leads, and an acquirer reads the pair as a company that two informed buyers looked at and neither took. The defence works when the second name sits at a different layer of the value chain, a customer-side corporate against a supplier-side one, and it backfires when the two are direct rivals. If the only available second strategic is their competitor, take a financial lead at the lower price instead.
If the strategic is already on the register and no financial anchor exists, the next round is where this gets corrected, and the correction is worth paying for. A smaller cheque from a credible fund at a flat price does more for how your register reads than a larger one from another corporate at a higher one.
What the three say together
- Name the second purchase. Read the terms, not the valuation, and price each free option they contain.
- Take the money, refuse the options. No right of first refusal, information rights matched to other investors, commercial terms in a separate arm’s-length agreement.
- Mark your customer and supplier list for anyone who competes with them, before you sign.
- Do not let them be the only strategic and the only lead. A financial anchor or a second group changes how the register reads.
Where they disagree
The selection argument and the inference argument disagree about whether the fix is in the terms or in the fact.
The selection argument says the problem is contractual: strip the free options and the deal becomes an ordinary investment at a good price, which is worth having. The inference argument says the terms are not what future buyers read. They read the name on the register, and no amount of clean drafting changes what a competing acquirer concludes when they see a rival’s logo in your cap table.
The reconciliation is about how visible the holding is and how large. A small, non-controlling position alongside financial investors is mostly a contractual question and the drafting does the work. A lead position with a board seat is a fact about your company that the market will read, and the terms are close to irrelevant to that reading. The threshold is not a percentage; it is whether a stranger describing your company would mention them. If they would, you are in the second case.
What none of them contain
None of the three prices what the strategic actually delivers. Distribution through a large partner can be worth more than every cost in this article, and none of these lenses measures it. The honest version of the decision weighs a specific, dated commercial commitment against the costs here, and if the commercial commitment is not specific and dated, there is nothing on that side of the scale.
None of them handles the market where strategics are the only available capital. In several African sectors the corporate and development-finance route is not one option among several, and an analysis that assumes you can decline is describing a different market.
And one property the ensemble will not produce: people move. The executive who championed you leaves, and their successor inherits a position they did not choose and a relationship they have no stake in. Every model here treats the investor as a stable entity, and the relationship you negotiated is frequently with one person.
The one action that survives the ignorance: before signing, write one sentence naming what this investor is buying beyond the equity. If you cannot write it, you have not finished the diligence, and the party who can write it is on the other side of the table.
Who has to move
The founder, and the work belongs before the term sheet rather than during the legal review, because by then the free options are drafted as standard and removing them looks like a late renegotiation. The instinct when a strategic offers above market is to treat the price as the negotiation and the rest as boilerplate, which is precisely inverted. The cheapest first test is the customer and supplier mark-up, which takes twenty minutes with a list you already have and occasionally ends the conversation on its own.
Sources and notes
- Jeffrey Carpenter and Andrea Robbett, Game Theory and Behavior, MIT Press. Adverse selection and the general result that the availability of terms carries information about the party offering them are developed in the chapters on asymmetric information. Used in section 1. The specific application, that a price better than the market’s indicates a second good being purchased at the same time, follows from the standard treatment rather than being a stated result in it.
- Albert-László Barabási, Network Science, Cambridge University Press. Spreading processes and the dependence of propagation on existing contact structure are developed in the chapters on spreading phenomena. Used in section 2 for the claim that a commercial relationship travels along connections that already exist rather than staying inside its contract. No claim is made about the topology of any specific market.
- Jeffrey Carpenter and Andrea Robbett, Game Theory and Behavior, MIT Press. Information cascades, in which decision-makers follow observed choices rather than their own weak private signals, and the fragility of a cascade to a single credible public fact, are treated in the chapters on social learning. The underlying results are due to Bikhchandani, Hirshleifer and Welch, and to Banerjee, both 1992. Used in section 3, applied to acquirers reading a cap table rather than to consumers observing purchases.
- George J. Mailath and Larry Samuelson, Repeated Games and Reputations: Long-Run Relationships, Oxford University Press. The treatment of long-run relationships and of what makes a commitment credible supports the recommendation in the blind-spot section that a strategic’s commercial promise counts only when it is specific and dated, since an unenforceable intention carries no weight in a repeated relationship where the other party’s horizon is much longer than yours.
A note on a number this article does not give. There is no percentage above which a strategic holding becomes a problem. The threshold is whether a stranger describing your company would mention them, which is a question about visibility rather than about ownership, and you can answer it by asking two people outside the company to describe you.
Joshua Agonya Pi’Rwot, Founder.